All stocks of SK bioscience are common stock, and our largest shareholder is SK chemicals, which owns % of the shares as of December 31, Find the latest SK Bioscience Co Ltd () stock forecast, month price target, predictions and analyst recommendations. SK Bioscience Estimates* in KRW ; EPS, , ; P/E Ratio, , ; EBIT, ,, , ; EBITDA, ,, -2, SK Bioscience Co Ltd. options quotes data for sells and puts, including KR last price, change and volume. Discover all the factors affecting SK Bioscience Co's share price. is currently rated as a Falling Star | Stockopedia.
SK bioscience Co., Ltd. engages in the development and distribution of bio and vaccine products. The company was founded on July 1. Stock information · Nominal. KRW · Start of trading. 18/03/ Stock analysis for SK Bioscience Co Ltd (Korea SE) including stock price, stock chart, company news, key statistics, fundamentals and company. SK bioscience Co.,Ltd. Stock Earnings Reports. Korea Exchange. Watchlist What are SK bioscience Co.,Ltd.'s retained earnings? On its balance sheet. Based on the latest financial disclosure, 69% of SK Bioscience Co are shares owned by insiders. This is % higher than that of the Healthcare sector and. Get the latest SK Bioscience Co Ltd () real-time quote, historical performance, charts, and other financial information to help you make more informed. View the latest SK Bioscience Co Ltd. () stock price, news, historical charts, analyst ratings and financial information from WSJ. Name: SK bioscience Co.,Ltd. · Ticker: A · Exchange: KOSE · Founded: · Industry: Biotechnology · Sector: Pharmaceuticals & Biotech · Market Cap: ₩t. According to the CMO agreement, SK bioscience will produce the stock solutions of AZD AstraZeneca through technical cooperation between the two companies. Shareholders: SK bioscience Co.,Ltd. ; Sjunde AP-fonden. %. 43,, %, 2 M ₩ ; Mercer Global Investments Europe Ltd. %. 16,, %, Shares of South Korean vaccine developer SK Bioscience Co Ltd debuted at double its IPO price on Thursday, as investors chased South Korea's biggest IPO in.
Stock analysis for SK Bioscience Co Ltd (D:KS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. South Korea's SK Bioscience to buy control of Germany's IDT Biologika for $ mln. June 26, Reuters logo ; Novavax to sell 7% stake to South Korea's SK. See the company profile for SK bioscience Co.,Ltd. (KS) including business summary, industry/sector information, number of employees. Stock Quotes ; 79,/ 49, · +/ / / The ticker symbol for SK Bioscience is What is the current stock price of SK Bioscience? As of Jul the stock price of SK Bioscience is $ Samsung Biologics Co Ltd. ₩, % ; Hanmi Pharm Co Ltd. ₩, % ; SK Bioscience Co Ltd. ₩55, % ; GC Biopharma. SK bioscience is committed to establishing a corporate culture and system for sustainable growth. The current price of is 55, KRW — it has increased by % in the past 24 hours. Watch SK BIOSCIENCE stock price performance more closely on the. SK bioscience Co.,Ltd. ; Tangible Book Value per Share. 98, 3, 4, ; Basic Weighted Avg Shares. 2.
Name: SK bioscience Co.,Ltd. · Ticker: A · Exchange: KOSE · Founded: · Industry: Biotechnology · Sector: Pharmaceuticals & Biotech · Market Cap: ₩t. | Complete SK Bioscience Co Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. SK bioscience Co.,Ltd. ; Tangible Book Value per Share. 98, 3, 4, ; Basic Weighted Avg Shares. 2. · 1. Report on the operation status of the internal accounting management system · 2. Report on the plan to support loans for employee stock ownership. No dividends history available for SK Bioscience Co Ltd.
Stock analysis for SK Bioscience Co Ltd (D:KS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. As on 14th Sep STOCK Price closed @ and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of & Strong Sell for SHORT-TERM. Their stock opened with ₩65, in its Mar 18, IPO. Stock Symbol KRX SK bioscience Co.,Ltd. KS Financial and Trading Overview ; Day's Range, - KRW ; 52 Week Range, - KRW ; Volume, K KRW ; Avg. Based on the latest financial disclosure, 69% of SK Bioscience Co are shares owned by insiders. This is % higher than that of the Healthcare sector and.